Zobrazeno 1 - 4
of 4
pro vyhledávání: '"59"'
Autor:
Wong TY; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Russ BP; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Lee KS; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Miller OA; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Kang J; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Cooper M; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Winters MT; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA., Rodriguez-Aponte SA; Department of Biological Engineering, Massachusetts Institute of Technologygrid.116068.8, Cambridge, Massachusetts, USA.; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technologygrid.116068.8, Cambridge, Massachusetts, USA., Dalvie NC; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technologygrid.116068.8, Cambridge, Massachusetts, USA.; Department of Chemical Engineering, Massachusetts Institute of Technologygrid.116068.8, Cambridge, Massachusetts, USA., Johnston RS; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technologygrid.116068.8, Cambridge, Massachusetts, USA., Rader NA; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Wong ZY; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Cyphert HA; Department of Biological Sciences, Marshall University, Huntington, West Virginia, USA., Martinez I; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; West Virginia Universitygrid.268154.c Cancer Institute, Morgantown, West Virginia, USA.; School of Medicine, Morgantown, West Virginia, USA., Shaligram U; Serum Institute of India Pvt. Ltd., Pune, Maharashtra, India., Batwal S; Serum Institute of India Pvt. Ltd., Pune, Maharashtra, India., Lothe R; Serum Institute of India Pvt. Ltd., Pune, Maharashtra, India., Chandrasekaran R; Serum Institute of India Pvt. Ltd., Pune, Maharashtra, India., Nagar G; Serum Institute of India Pvt. Ltd., Pune, Maharashtra, India., Rajurkar M; Serum Institute of India Pvt. Ltd., Pune, Maharashtra, India., Rao H; Serum Institute of India Pvt. Ltd., Pune, Maharashtra, India., Bevere JR; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Barbier M; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA., Love JC; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technologygrid.116068.8, Cambridge, Massachusetts, USA.; Department of Chemical Engineering, Massachusetts Institute of Technologygrid.116068.8, Cambridge, Massachusetts, USA., Damron FH; Department of Microbiology, Immunology, and Cell Biology, West Virginia Universitygrid.268154.c, Morgantown, West Virginia, USA.; Vaccine Development Center at West Virginia Universitygrid.268154.c Health Sciences Center, Morgantown, West Virginia, USA.
Publikováno v:
MSphere [mSphere] 2022 Aug 31; Vol. 7 (4), pp. e0024322. Date of Electronic Publication: 2022 Aug 15.
Autor:
Bordoy AE; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.; Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain.; SeqCOVID-SPAIN consortium, Valencia, Spain., Vallès X; Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain.; Programa de Salut Internacional, Institut Català de la Salut, Barcelona, Spain., Not A; Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain.; SeqCOVID-SPAIN consortium, Valencia, Spain., Chiner-Oms Á; SeqCOVID-SPAIN consortium, Valencia, Spain.; Instituto de Biomedicina de Valencia (IBV-CSIC), Valencia, Spain., Saludes V; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.; Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain.; SeqCOVID-SPAIN consortium, Valencia, Spain.; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Torres Cervós J; Fundació Pere Mata, Barcelona, Spain., Roset Roig A; Fundació Pere Mata, Barcelona, Spain., Juan-Andres C; Equip d'Atenció Primària Alt Mogent, Direcció d'Atenció Primària Regió Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain., Sureda H; Equip d'Atenció Primària Alt Mogent, Direcció d'Atenció Primària Regió Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain., Pardo-Amil V; Equip d'Atenció Primària Alt Mogent, Direcció d'Atenció Primària Regió Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain., García I; Àrea de Suport Assistencial, Direcció d'Atenció Primària-Vallès Oriental, Institut Català de la Salut, Barcelona, Spain., Guitart Rossell G; Fundació Pere Mata, Barcelona, Spain., Cambra Cibeira L; Fundació Pere Mata, Barcelona, Spain., Casañ C; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.; SeqCOVID-SPAIN consortium, Valencia, Spain., Giménez M; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain., Blanco I; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain., Torres-Puente M; SeqCOVID-SPAIN consortium, Valencia, Spain.; Instituto de Biomedicina de Valencia (IBV-CSIC), Valencia, Spain., Cancino-Muñoz I; SeqCOVID-SPAIN consortium, Valencia, Spain.; Instituto de Biomedicina de Valencia (IBV-CSIC), Valencia, Spain., González-Candelas F; SeqCOVID-SPAIN consortium, Valencia, Spain.; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Joint Research Unit 'Infection and Public Health' FISABIO-University of Valencia I2SysBio, Valencia, Spain., Comas I; SeqCOVID-SPAIN consortium, Valencia, Spain.; Instituto de Biomedicina de Valencia (IBV-CSIC), Valencia, Spain.; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Martró E; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Barcelona, Spain.; Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain.; SeqCOVID-SPAIN consortium, Valencia, Spain.; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Publikováno v:
MSphere [mSphere] 2022 Dec 21; Vol. 7 (6), pp. e0034622. Date of Electronic Publication: 2022 Nov 30.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antoni E. Bordoy, Xavier Vallès, Anna Not, Álvaro Chiner-Oms, Verónica Saludes, Judit Torres Cervós, Anna Roset Roig, Concha Juan-Andres, Helena Sureda, Vanessa Pardo-Amil, Irene García, Gemma Guitart Rossell, Laura Cambra Cibeira, Cristina Casañ, Montserrat Giménez, Ignacio Blanco, Manuela Torres-Puente, Irving Cancino-Muñoz, Fernando González-Candelas, Iñaki Comas, Elisa Martró
Publikováno v:
mSphere, Vol 7, Iss 6 (2022)
ABSTRACT Limiting outbreaks in long-term care facilities (LTCFs) is a cornerstone strategy to avoid an excess of COVID-19-related morbidity and mortality and to reduce its burden on the health system. We studied a large outbreak that occurred at an L
Externí odkaz:
https://doaj.org/article/bc08f6bb060544eb9f1d6ce53f2a8303